You are here

Eli Lilly and Company

Member Since 2006

Anne White

Senior Vice President and President, Lilly Oncology

Anne has held a range of roles in drug development across multiple therapeutic areas, including oncology, neuroscience and infectious diseases. She has led the development of multiple late-phase opportunities and has led teams in successfully submitting and achieving new drug approvals for several new medicines. Anne has also had roles leading early phase drug development and patient tailoring in oncology. Her current and past responsibilities include global leadership and direction of several significant change transformations resulting in improved speed, efficiency and increased organizational health.

Most notably, Anne has led Lilly’s effort to speed drug development, from target identification through successful launch. Anne served most recently as vice president of Portfolio Management, Chorus and Next Generation Research and Development, with previous roles of vice president of Oncology Clinical Development and chief operating officer for oncology. She has over 25 years of experience in the pharmaceutical industry.

Anne also has experience in small-company pharma, having founded and led a startup company in oncology drug development, collaborating with the Moffitt Cancer Center and the National Cancer Institute. Anne earned a bachelor’s degree in engineering from the University of Michigan.

Anne was awarded the Lilly Women’s Network Award for her efforts in mentoring and supporting women in the workplace. She was named to the first President’s Council in Lilly Research Laboratories in recognition for her leadership and impact on others.

CEO Cancer Gold Standard™

Gold Standard  Employer

Since 2011


At Lilly, our commitment to making life better goes beyond the medicines we make - it’s at the very heart of our business. We are honored to have been designated a CEO Cancer Gold Standard accredited corporation, which underscores the importance we place on the well-being of our employees. We in Lilly Oncology, continually strive to create an environment of wellness for our employees, one that provides them with the preventive care and education they need to live happy, healthy and productive lives.

— Anne White

Gold Standard  Task Force Participation

Task Force Member(s): Leslie M Ayres, RN, Manager Corporate Health Services; Charles Williams, Senior Director - Corporate Health Services

Life Sciences Consortium

LSC  Task Force Participation

Task Force Member(s): Susan Mahony, PhD, Senior Vice President and President, Lilly Oncology; Anwar M. Hossain, Research Scientist

Member: Anwar M. Hossain, Research Scientist

Project Data Sphere, LLC

an independent initiative of the Life Sciences Consortium

Data Provider

Since 2015

Eli Lilly and Company

Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.

We were founded in 1876 by Colonel Eli Lilly, a man committed to creating high-quality medicines that meet real needs. More than a century later, we are passionate about building on this precedent in our continued pursuit to make life better for individuals, communities, and the world around us.

Our heritage and our values are the foundation of our promise to unite caring with discovery to make life better for people around the world.

Our mission
We make medicines that help people live longer, healthier, more active lives.

Our values
Integrity, excellence, respect for people

Our vision
We will make a significant contribution to humanity by improving global health in the 21st century.